| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | GARTNER, INC. CMN | Aug 26, 2025 | |
| Buy | GOODRX HOLDINGS INC | Jul 10, 2025 | |
| Buy | GOODRX HOLDINGS INC CMN | Apr 13, 2022 | |
| Buy | GOODRX HOLDINGS INC CMN CLAS | Mar 31, 2022 |
This page tracks congressional stock trading activity in GoodRx Holdings, Inc. (GDRX) in the Healthcare sector. Disclosed Capitol has indexed 4 disclosed congressional trades involving GDRX. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of September 2025 — Disclosed Capitol has tracked 4 disclosed congressional trades in GoodRx Holdings, Inc. (GDRX) — 3:1 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Aug 26, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Jul 10, 2025 | Greg Steube | R | Purchase | $15,001 - $50,000 |
| Apr 13, 2022 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Mar 31, 2022 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 4 disclosed congressional trades in GoodRx Holdings, Inc. (GDRX), members of Congress have reported 3 buys and 1 sell. The average 30-day alpha vs. the S&P 500 is -26.72%.
As of August 2026, corporate insiders at GoodRx Holdings, Inc. have filed 18 SEC Form 4 transactions in GDRX over the past 12 months — including 14 sells worth $9.7M.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-08-26 | Francisco Partners Management, LP | Sale | $750K |
| 2026-08-26 | Francisco Partners Management, LP | Sale | $739K |
| 2026-08-26 | Francisco Partners Management, LP | Sale | $1.5M |
| 2026-08-26 | Francisco Partners Management, LP | Sale | $1.5M |
| 2026-08-25 | Francisco Partners Management, LP | Sale | $221K |
| 2026-08-25 | Francisco Partners Management, LP | Sale | $218K |
| 2026-08-24 | Francisco Partners Management, LP | Sale | $250K |
| 2026-08-24 | Francisco Partners Management, LP | Sale | $247K |
| 2026-08-21 | Francisco Partners Management, LP | Sale | $484K |
| 2026-08-21 | Francisco Partners Management, LP | Sale | $477K |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.
For fiscal year 2025, GoodRx Holdings, Inc. reported revenue of $796.9M and net income of $30.4M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $394.4M, net income $9.7M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.